Early Tumor Burden Dynamics on CT Scans to Predict Clinical Outcome In Advance NSCLC Patients Undergoing First-line Immune Checkpoint Inhibitors or First-line Chemo-Immunotherapy

Written By Stephanie Avila

Lucia Maffucci | Department of Medicine and Surgery, University of Parma, Italy

Stephanie Avila
Previous

CT Features Predicting Fissure Visceral Pleural Invasion and Recurrence in Fissure-Connected Lung Cancer < 30 mm
Next

Identifiaction of High-Risk Recurrence Patients in Stage I-III NSCLC through Integration of Radiological Tumor Volume and Minimal Residual Disease